BridGene Biosciences logo

BridGene Biosciences

Utilizing advanced chemoproteomic technology to discover and develop highly selective small molecules for traditionally undruggable targets.

11-50 employees · est. 2018

VS
Rubedo Life Sciences logo

Rubedo Life Sciences

Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging

32 employees · est. 2018 · Sunnyvale, United States

Side-by-Side Comparison

BridGene Biosciences Rubedo Life Sciences
Founded
2018 2018
Headquarters
Not tracked yet Sunnyvale, United States
Employees
11-50 32
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care, Life Sciences
Funding Stage
Series B Series A
Total Funding
$50.50M $53.45M
Funding Rounds
2 7
Services
Development of Small Molecule Therapies, Covalent Drug Discovery, Pipeline Management, Collaborative Therapeutic R&D, Chemoproteomics Platform Drug discovery and development, Clinical trials for anti-aging and chronic disease therapies, Research in biology of aging
Target Customers
Pharmaceutical Companies, Biotech Firms, Healthcare Institutions, Research Organizations, Clinicians and Medical Researchers Patients with chronic diseases, Individuals seeking longevity and anti-aging solutions, Healthcare providers, Scientific researchers
Taxonomy
Chemoproteomics, Small Molecules, Drug Discovery, Undruggable Targets, Covalent Small Molecules, Proteome-wide Screening, Live Cell Screening, Protein Targeting, Selective Small Molecules, Advanced Technology, Drug Development Biopharmaceutical, Drug Discovery, Senescent Cells, Chronic Diseases, Innovative Therapies, Small Molecules, Pulmonary Diseases, Dermatological Diseases, Oncological Diseases, Neurodegenerative Diseases, Fibrotic Diseases, Biotech Innovators, Sunnyvale, California, Drug Development
Website
bridgenebio.com rubedolife.com
BridGene Biosciences logo

About BridGene Biosciences

BridGene Biosciences stands at the cutting edge of biotechnology with a unique focus on chemoproteomics. Founded in 2018, the company is pioneering solutions in the Biotechnology and Health and Wellness industries. BridGene's innovative approach utilizes advanced chemoproteomic technology to discove...

Rubedo Life Sciences logo

About Rubedo Life Sciences

Rubedo Life Sciences, founded in 2018, is a promising player in the biotechnology, healthcare, and life sciences sectors. Headquartered in Sunnyvale, CA, this biopharmaceutical company is heralding a new era in age-related disease treatment with its pioneering approach. The company is known for its...

We will tell you when either one moves

BounceWatch watches BridGene Biosciences and Rubedo Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BridGene Biosciences and Rubedo Life Sciences — by email.

Frequently Asked Questions

BridGene Biosciences — Utilizing advanced chemoproteomic technology to discover and develop highly selective small molecules for traditionally undruggable targets.. Rubedo Life Sciences — Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BridGene Biosciences has raised $50.50M while Rubedo Life Sciences has raised $53.45M.
BridGene Biosciences and Rubedo Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BridGene Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BridGene Biosciences on 3 Apr 2026, and Rubedo Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy